BIOECON
Reference
Technologies
Companies
Tenders
About
⌕
Search
⌘K
CN
EN
RU
Find Supplier →
Bioecon
›
Technologies
›
Mrna
technology
Mrna
Where it's used
mRNA platforms & LNP delivery
Synthetic mRNA in lipid nanoparticles (60–100 nm) turns the cell into a bioreactor — from a vaccine platform to personalised cancer immunotherapy and in-vivo protein expression.
therapeutics-platforms
4 min
Search
esc
↵
open
esc
close
pagefind